Adenoviridae Infections - 138 Studies Found
| Completed |
: ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers : Malignant Solid Tumour : 2012-04-19 : Genetic: ONCOS-102 GMCSF encoding 3/5 chimeric adenovirus for intratumoral and intravenous injection on |
| Withdrawn |
: Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma : Esophageal Neoplasms : 2006-05-22 : Genetic: CD40 Gene Transfer gene transfer, intratumoral administration |
| Withdrawn |
: Trial of E10A in Head and Neck Cancer :
: 2008-03-05 :
|
| Completed |
: A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults : Virus Diseases : 2015-06-18 :
|
| Active, not recruiting |
: A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children : Virus Diseases : 2015-09-10 :
|
| Completed |
: Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer : Colon Cancer : 2013-10-24 : Biological: Ad5-hGCC-PADRE vaccine A single intramuscular dose (100 billion virus particles) of Ad5-hGCC |
| Completed |
: Allogeneic Virus-specific T Cell Lines (VSTs) : Viral Infections After HSCT : 2015-07-13 : Biological: VSTs most closely HLA-matched multivirus-specific T cell lines obtained from a bank of allog |
| Active, not recruiting |
: Virus DNX2401 and Temozolomide in Recurrent Glioblastoma :
: 2013-09-27 : Procedure: DNX2401 and Temozolomide Virus injection in the |
| Completed |
: Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer : Prostate Cancer : 2005-06-27 : Biological: CV787 (CG7870) |
| Completed |
: Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT : Infectious Complications Following HSCT : 2015-10-21 : Other: antiviral therapies for CMV and/or ADV salvage antiviral treatments for ADV and/or CMV |